Drug Chemistry and Toxicology CHE 618 Alexander Nazarenko.

Slides:



Advertisements
Similar presentations
Enzymes.
Advertisements

LAKSHMAN KARALLIEDDE OCTOBER 2011
DRUG-RECEPTOR INTERACTIONS
Enzymes and Coenzymes I Dr. Sumbul Fatma Clinical Chemistry Unit Department of Pathology.
Enzyme Kinetic Zhi Hui.
Chapter 7 Chem 341 Suroviec Fall I. Introduction The structure and mechanism can reveal quite a bit about an enzyme’s function.
Drug ? RESPONSE altering their biochemical &/or biophysical activity  Depress  Activate  Replace  Irritate  Destroy PHARMACODYNAMICS  Absorb 
Lecture 2 CHE 618. Agonists Partial Agonist Antagonist Inverse Agonist.
Pharmacology-1 PHL 313 Fourth Lecture By Abdelkader Ashour, Ph.D. Phone:
Enzyme Kinetics and Catalysis II 3/24/2003. Kinetics of Enzymes Enzymes follow zero order kinetics when substrate concentrations are high. Zero order.
Chapter 8 Applications In physics In biology In chemistry In engineering In political sciences In social sciences In business.
Inhibited Enzyme Kinetics Inhibitors may bind to enzyme and reduce their activity. Enzyme inhibition may be reversible or irreversible. For reversible.
Drug-Receptor Interactions Pharmacodynamics
RESPONSE To alter their biochemical &/or biophysical activity  Depress  Activate  Replace  Irritate  Destroy PHARMACODYNAMICS  Absorb  Distribute.
RESPONSE To alter their biochemical &/or biophysical activity  Depress  Activate  Replace  Irritate  Destroy PHARMACODYNAMICS  Absorb  Distribute.
Principles of Pharmacology: Pharmacodynamics
DRUG RECEPTOR INTERACTIONS
Receptor and Signal Transduction Receptor Concept Dept. Pharmacology, Tzu Chi Univ. T.H. Chiu I. References for the lecture II. Development of receptor.
Principles of Pharmacology: Pharmacodynamics
Quantifying the drug-target binding affinity. Receptors as targets (Receptors are 45% of current drug targets) Receptors are areas of proteins found in.
Section 1, Lecture 7 Pharmacodynamics
PHC 222 Part(I) Dr. Huda Al Salem Lecture (7). Factors that affect the efficacy 2- Concentration-Response Curves: Agonist Antagonist Partial agonist Desensetization.
Enzymes (If you don’t have the energy, we can help!)
Pharmacology UG-Course Touqeer Ahmed PhD 19 th February, 2015 Atta-ur-Rahman School of Applied Biosciences National University of Sciences and Technology.
Why study enzyme kinetics?  To quantitate enzyme characteristics  define substrate and inhibitor affinities  define maximum catalytic rates  Describe.
Enzymes are protein molecules that are able to catalyse a biological reaction.
Prof. R. Shanthini 23 Sept 2011 Enzyme kinetics and associated reactor design: Determination of the kinetic parameters of enzyme-induced reactions CP504.
BASIC PHARMACOLOGY 2 SAMUEL AGUAZIM(MD).
RESPONSE altering their biochemical &/or biophysical activity  Depress  Activate  Replace  Irritate  Destroy PHARMACODYNAMICS  Absorb  Distribute.
Enzyme Catalysis SBS017 Basic Biochemistry Dr John Puddefoot
HuBio 543 September 6, 2007 Frank F. Vincenzi
Lecture – 4 The Kinetics of Enzyme-Catalyzed Reactions Dr. AKM Shafiqul Islam School of Bioprocess Engineering University Malaysia Perlis
AH Biology: Unit 1 Proteomics and Protein Structure 3
Lock and Key Model Enzymes are specific to their substrates Substrate and active site match each other in two ways: Structurally  substrates that don’t.
Lab: principles of protein purification
PHARMACODYNAMICS M.T. Piascik PHA 824 November 11, 2008.
Rmax and Km (26.4) Constants from Michaelis-Menten equation give insight into qualitative and quantitative aspects of enzyme kinetics Indicate if enzyme.
R max and K m (26.4) Constants from Michaelis-Menten equation give insight into qualitative and quantitative aspects of enzyme kinetics Constants – Indicate.
Dr. Laila M. Matalqah Ph.D. Pharmacology Pharmacodynamics 1 General Pharmacology M212.
Receptor Theory & Toxicant-Receptor Interactions Richard B. Mailman.
RESPONSE To alter their biochemical &/or biophysical activity  Depress  Activate  Replace  Irritate  Destroy PHARMACODYNAMICS  Absorb  Distribute.
Dr. Laila M. Matalqah Ph.D. Pharmacology Pharmacodynamics 2 General Pharmacology M212.
Clinical Pharmacokinetics. Time course Duration Onset Absorptive phase Elimination phase.
Prof. hanan Hagar.  Identify different targets of drug action Ilos Elaborate on drug binding to receptors Differentiate between their patterns of action;
Title: Lesson 4 B.2 Enzymes Learning Objectives: – Describe the structure and the function of an enzyme – Identify and explain the factors that affect.
DRUG RECEPTORS AND PHARMACODYNAMICS
INTRODUCTION Lecture 3. Pharmacodynamics Receptor: macromolecule that interacts with a drug and initiates the chain of biochemical events leading to the.
IN THE NAME OF GOD.
Pharmacodynamics What the drug does to the body?
Pharmacodynamics. * The study of the biochemical and physiologic effects of drugs and the molecular mechanisms by which those effects are produced * The.
Interpretation of Michaelis Menten Equation. Michaelis-Menten  Graphically representation:
Receptor Theory & Toxicant-Receptor Interactions
Enzymes.
Understanding the Basics of Pharmacology
ENZYME INHIBITION.
Drug-Receptor Interactions
INTRODUCTION to Pharmacology
Pharmacodynamics 2.
Pharmacology UG-Course
Drug-Receptor Interactions
Pharmacology UG-Course
Pharmacodynamic Dr. Hashem Mansour.
Introduction to Pharmacology
By Amany Helmy Hasanin Assistant Professor of Clinical Pharmacology
Efficacy, Potency and Safety of Drugs
Introduction to Pharmacology
Drug-Receptor Interactions and Pharmacodynamics (cont.)
Drug-Receptor Interactions
Drug- Receptor Interaction
Full agonists The “agonists” referred to so far are FULL AGONISTS
Presentation transcript:

Drug Chemistry and Toxicology CHE 618 Alexander Nazarenko

The Receptor Concept The Nature of Drug Receptors Drug Parameters: Affinity and Efficacy The Langmuir Isotherm equation

Opioid receptor Insulin receptor Transmembrane receptor

Occupation theory Drug effect is directly proportional to number of receptors occupied Drug effect ceases as drug-receptor complex dissociate Ariens & Stephenson theory introduced terms of "affinity" & "efficacy" Affinity: ability of the drug to combine with receptor to create drug-receptor complex Efficacy: ability of the drug-receptor complex to initiate a response Affinity “drug-receptor interaction” is governed by the law of mass action. In this theory Agonist: drug with high affinity & high intrinsic activity Partial agonist: drug with high affinity & low intrinsic activity Antagonist: drug with high affinity & low intrinsic activity Rate theory The activation of receptors is directly proportional to the total number of encounters of the drug with its receptors per unit time Pharmacological activity is directly proportional to the rate of dissociation & association not number of receptors occupied Agonist: drug with fast association & fast dissociation Partial agonist: drug with intermediate association & intermediate dissociation Antagonist: drug with fast association & slow dissociation Induced fit theory As the drug approaches the receptor the receptors alters the conformation of its binding site to produce drug—receptor complex

From the Greek αγωνιστής (agōnistēs), contestant; champion; rival < αγων (agōn), contest, combat; exertion, struggle < αγω (agō), I lead, lead towards, conduct; drive An agonist is a chemical that binds to a receptor and triggers a response. Whereas an agonist causes an action, an antagonist blocks the action of the agonist and an inverse agonist causes an action opposite to that of the agonist.

Drug + Receptor[Drug/Receptor Complex] Action K

β = 100K = 1/100 = 0.01 The Langmuir Isotherm

1/a 1/C a C C/a C Various plots Lineweaver–Burk plot Hanes–Woolf plot

Lineweaver–Burk or double-reciprocal plot of kinetic data, showing the significance of the axis intercepts and gradient. Michaelis-Menten Plot relating the reaction rate V to the substrate concentration [S]. Michaelis–Menten kinetics

Agonists Partial Agonist Antagonist Antagonists bind to receptors but do not activate them. This results in receptor blockage, inhibiting the binding of other agonists. Inverse Agonist Partial agonists do not activate receptors thoroughly, causing responses which are partial compared to those of full agonists Full agonists are able to activate the receptor and result in a maximal biological response. Inverse agonists reduce the activity of receptors by inhibiting their constitutive activity.

+1 0 Functional Response Log[Drug] Full Agonist Partial Agonist Neutral Antagonist Full Inverse Agonist

Competitive Antagonism A1 + Receptor{A1 Receptor} effect A2 + Receptor {A2 Receptor}

R A1 A2 R A1 R A2 R A1 A2 Receptor-A1 is active Receptor-A1-A2 is active

Similar: In coordination chemistry Metal Ion + Ligand 1 + Ligand 2 In enzyme kinetics Enzyme + Substrate + Inhibitor

Dose-response curve What is there that is not poison? All things are poison and nothing without poison Solely the dose determines that a thing is not a poison